Search
Close this search box.

Newsroom

Newsroom

Jinming Gao-crop 2
New immunotherapy drug boosts innate immune system to fight cancer
February 8, 2021
Publications
Research, Discovery, Immunotherapy

New immunotherapy drug boosts innate immune system to fight cancer

February 8, 2021
Research, Discovery, Immunotherapy
Publications

A newly released study in Nature Biomedical Engineering by Jinming Gao, Professor of Oncology, Pharmacology, and Otolarynology, shows how a novel, nanoparticle-based drug may be more effective at engaging the body’s innate immune system to fight cancer. The drug’s unique and prolonged binding to the STING protein was associated with longer innate immune activation, demonstrating a more effective T cell response against solid tumors. PRESS RELEASE

CellPress 2
Novel ccRCC evolutionary model
November 5, 2020
Publications
Research, Discovery

Novel ccRCC evolutionary model

November 5, 2020
Research, Discovery
Publications
Drawing from a recent report of ccRCC subtypes based on gene expression (from a Genentech-sponsored clinical trial), as well as pioneering genomic discoveries and mouse models from the Kidney Cancer Program, Drs. Brugarolas and Kapur present an updated evolutionary model of clear cell renal cell carcinoma development. Article

Drawing from a recent report of ccRCC subtypes based on gene expression (from a Genentech-sponsored clinical trial), as well as pioneering genomic discoveries and mouse models from the Kidney Cancer Program, Drs. Brugarolas and Kapur present an updated evolutionary model of clear cell renal cell carcinoma development. Article

CDMRP 2
CDMRP-funded National Kidney Cancer Academy hosts meeting for new investigators
November 5, 2020
Event
Education, Research

CDMRP-funded National Kidney Cancer Academy hosts meeting for new investigators

November 5, 2020
Education, Research
Event
November 5 marks the first workshop for kidney cancer investigators participating in the National Kidney Cancer Academy, funded by the CDMRP’s (Congressionally Directed Medical Research Program) Kidney Cancer Research Program. New investigator award recipients Drs. David Braun (Dana-Farber Cancer Institute), Abishek Chakraborty (Cleveland Clinic), and Lucas Salas (Dartmouth Geisel School of Medicine) discussed their research plans with Dr. Brian Rini (Vanderbilt-Ingram Cancer Center), Dean of the Academy, along with members of the Advisory Board, which is chaired by KCP Director Dr. James Brugarolas, and other kidney cancer experts.

November 5 marks the first workshop for kidney cancer investigators participating in the National Kidney Cancer Academy, funded by the CDMRP’s (Congressionally Directed Medical Research Program) Kidney Cancer Research Program. New investigator award recipients Drs. David Braun (Dana-Farber Cancer Institute), Abishek Chakraborty (Cleveland Clinic), and Lucas Salas (Dartmouth Geisel School of Medicine) discussed their research plans with Dr. Brian Rini (Vanderbilt-Ingram Cancer Center), Dean of the Academy, along with members of the Advisory Board, which is chaired by KCP Director Dr. James Brugarolas, and other kidney cancer experts.

Sept202020-James Chen_crop
Dr. James Chen receives Cancer Research Institute Award for groundbreaking discoveries on innate immunity
September 30, 2020
Recognition
Research, Immunotherapy

Dr. James Chen receives Cancer Research Institute Award for groundbreaking discoveries on innate immunity

September 30, 2020
Research, Immunotherapy
Recognition
Biochemist Dr. Zhijian “James” Chen receives the 2020 William B. Coley Award in recognition for his work on the cGAS-STING pathway and its potential to improve cancer immunotherapies

Biochemist Dr. Zhijian “James” Chen receives the 2020 William B. Coley Award in recognition for his work on the cGAS-STING pathway and its potential to improve cancer immunotherapies

Aug192020-tcells may hold key_crop
T cells may hold key to detecting early-stage cancer
August 19, 2020
Announcement
AI-Data Science, Immunotherapy

T cells may hold key to detecting early-stage cancer

August 19, 2020
AI-Data Science, Immunotherapy
Announcement
Dr. Bo Li, Assistant Professor of Bioinformatics at UTSW, and colleagues have developed a deep learning system designed to detect subtle changes in T cells as a means for recognizing cancer in its earlist stage, when it’s most easily treated.

Dr. Bo Li, Assistant Professor of Bioinformatics at UTSW, and colleagues have developed a deep learning system designed to detect subtle changes in T cells as a means for recognizing cancer in its earlist stage, when it’s most easily treated.

UTSW-Kidney-Cancer-SPORE-awards-five-investigators-with-funding-to-support-innovative-kidney-cancer-research
UTSW Kidney Cancer SPORE awards five investigators with funding to support innovative kidney cancer research
July 21, 2020
Recognition
Research, SPORE, Technology Development

UTSW Kidney Cancer SPORE awards five investigators with funding to support innovative kidney cancer research

July 21, 2020
Research, SPORE, Technology Development
Recognition
Five cancer researchers will be supported as part of the Kidney Cancer SPORE grant. Drs. Maralice Conacci-Sorrell, Ivan D’Orso, and Qing Zhang received Development Research Program awards and Junyu Guo and Peter Ly received Career Enhancement Program Awards. Their projects range from investigating a new target for HIF-2 resistant kidney cancer to developing a deep learning registration method for MRI imaging of tumors in the abdomen.

Five cancer researchers will be supported as part of the Kidney Cancer SPORE grant. Drs. Maralice Conacci-Sorrell, Ivan D’Orso, and Qing Zhang received Development Research Program awards and Junyu Guo and Peter Ly received Career Enhancement Program Awards. Their projects range from investigating a new target for HIF-2 resistant kidney cancer to developing a deep learning registration method for MRI imaging of tumors in the abdomen.

NCCN
Simmons Cancer Center elected to National Comprehensive Cancer Network
March 21, 2020
Recognition
Patient Care

Simmons Cancer Center elected to National Comprehensive Cancer Network

March 21, 2020
Patient Care
Recognition
As a member of the NCCN, UT Southwestern Medical Center’s Simmons Cancer Center faculty join faculty from 30 other top cancer institutions in the U.S. to develop NCCN Clinical Practice Guidelines, a recognized standard for clinical cancer care. Press Release

As a member of the NCCN, UT Southwestern Medical Center’s Simmons Cancer Center faculty join faculty from 30 other top cancer institutions in the U.S. to develop NCCN Clinical Practice Guidelines, a recognized standard for clinical cancer care. PRESS RELEASE

Contact
MAILING ADDRESS
5323 Harry Hines Blvd. Dallas, Texas 75390-8852
PHYSICAL ADDRESS
icon-pin
6001 Forest Park Road, Suite ND3.504. Dallas, Texas 75235-8852
icon-phone
214-648-4059
icon-email
KCP@utsw.edu
Facebook-f Twitter Youtube
Contact
MAILING ADDRESS
icon-email
5323 Harry Hines Blvd. Dallas, Texas 75390-8852
icon-phone
214-648-4059
PHYSICAL ADDRESS
icon-pin
6001 Forest Park Road, Suite ND3.504. Dallas, Texas 75235-8852
icon-email
KCP@utsw.edu
Facebook-f Twitter Youtube
UTSW Kidney Cancer Program Logo
© 2024 UT Southwestern Kidney Cancer Program | Privacy | Terms and Conditions
Web Design By Red Spot Design